Patents by Inventor Chris E. Platt

Chris E. Platt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release oral preparation with naproxen sodium and pseudoephedrine
    Patent number: 6099860
    Abstract: Pharmaceutical compositions comprising from about 50 mg to 500 mg of the non-steroidal anti-inflammatory analgesic naproxen and from about 15 mg to 120 mg of the decongestant pseudoephedrine are provided in a controlled release oral preparation suitable for dosing every 12 hours in a therapy or cure of sinusitis, or sinus headaches, generally exemplified by discomfort, pain, pressure, and dizziness.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: August 8, 2000
    Inventor: Chris E. Platt
  • Timed release tablet comprising naproxen and pseudoephedrine
    Patent number: 5998478
    Abstract: Disclosed herein is a pharmaceutical composition comprising naproxen and the decongestant pseudoephedrine in a time release tablet form in the therapy of sinusitis, or sinus headaches, generally exemplified by discomfort, pain, pressure, and dizziness.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: December 7, 1999
    Inventor: Chris E. Platt
  • Topical preparation of tolnaftate and hydrocortisone to treat fungal infections of the skin
    Patent number: 5496812
    Abstract: A topical preparation of between 1% and 3% hydrocortisone and 1.5% and 4.5% tolnaftate, by weight, in a 2:3 ratio used for treating a fungal infection of the skin. The specified ratio provides an accelerated and non-toxic treatment.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: March 5, 1996
    Inventor: Chris E. Platt